Clinical Trial Update: A Two Week Nitazoxanidebased Quadruple Regimen [Phase 3]

View source ↗

Summary

A Phase 3 trial update describes a two-week nitazoxanide-based quadruple regimen for dyspepsia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• nitazoxanide-based quadruple regimen (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Dyspepsia | Phase 3 | Status: UNKNOWN